Ryan Confer Appointed Genprex President and CEO and to its Board of Directors AUSTIN, Texas, May 8, 2024 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer…